Non Surgical Pain Flashcards
common chronic pain conditions (4)
lumbar radiculopathy
facet arthroplathy
SI joint dysfunction
occipital neuritis
material released after trauma includes (8)
potassium plasma RBC/WBC's clotting factors peptides prostaglandins inflammatory cells
materials released after trauma are through to enhance
activation of membrane channels (Na/Ca/etc)
release of these two things cause vascular leaking leading to swelling
substance p
calcitonin
pain response without tissue injury
escape response consistent with intensity of stimulation
removal of stimulation terminates sensation and response
sensation is specific to a site of potential injury
initial sensation is sharp, followed by a dull sensation
if you sit on a thumb tack, describe the a fiber and c fiber response
a fibers: quickest to respond, sharp sensation
c fibers: if you dont remove yourself from the object, a fibers are transmitting less and c fibers transmit more, which is more of a dull pain
pain response with tissue injury
pain persists after removal of stimulus. stimulating injured tissue cause an intense response (hyperalgesia), lower threshold of stimulation required to elicit an adverse response, has both localized sensation and referred sensation
pain response with nerve injury description
ongoing unpleasant pain sensation usually referred to the dermatome innervated by the injured nerve (hyperalgesia)- pain greater than expected.
increased pain sensation with touch (allodynia). pain that should not be painful
evolution of chronic pain (5)
associated with nerve injury response (not always but mostly)
failure to treat nerve and tissue injury effectively
occult inflammation
failure of tissue healing
persistent inflammation
(any or all of these may result in a windup)
what encompasses a windup or “enhanced spinal response”
- neurotransmitters (3)
- cell effected
repetitive stimulation releases glutamate, neurokinin, substance P which overwhelms the magnesium block
channels are opened, proteins couple with receptors producing long lasting calcium release
glial cell dysfunction in dorsal horn can be appreciated
loss of central inhibition mechanisms
during the windup or enhanced spinal response, what encompasses the loss of central inhibition mechanisms
there is an increased intracellular calcium, release of arachidonic acid (irritant), creation of cyclooxygenase, cox synthesizes prostaglandins, which reduces glycine and GABA mediated inhibition, negative impact on NMDA receptors (stimulates them), promoting dorsal horn excitability
what happens to glycine and GABA in chronic pain
they transition from inhibitory to excitatory
what are the effects of NSAIDS
antipyretic, anti inflammatory, analgesia
aceta has little anti inflammatory activity
NSAID MOA
inhibits prostaglandin production from arachidonic acid by acetylation of cyclooxygenase
MOA of COX1
contributes to hemostasis and platelet aggregation
protects the gastric mucosa via prostacyclin production
MOA of COX2 (4)
produces inflammation
contributes to fever (cytokines)
stimulates pain sensation
supports prostacyclin anti coagulation activity
both are present peripherally and in the CNS
NSAID PK: absorption
PO in stomach and small intestines
food delays absorption
IV administration may not reduce negative gastric effects
topical absorption has advantages of local targeted effect
NSAID PK: peak concentration
1-4 hours
NSAID PK: distribution
weakly acidic, highly plasma bound, lipophilic, only unbound portion is effective
NSAID PK: elimination
hepatic oxidation and conjugation
less than 10% renal elimination
some active metabolites
propionic acid NSAID examples (2)
naproxen (aleve)
ibuprofen (advil, motrin)
(naproxen) aleve COX selectivity, half life, elimination
non selective
half life of 14 hours
renal excretion
ibuprofen (advil, motrin) cox selectivity, peak, protein binding, anti inflammatory dose
non selective
peaks in 1-2 hours
highly bound to plasma
anti inflammatory effective at doses >1600mg/day
acetic acid NSAID examples (3)
diclofenic (voltaren) (COX2)
indomethacin (non selective)
ketorolac (toradol) (non selective)
diclofenic (voltaren) cox selectivity, elimination, toxicity considerations, risk associated with it
COX2 selective
hepatic toxicity
transdermal use effective without systemic toxicity
increased risk of thrombotic event
indomethacin COX selectivity, SE to be aware of
non selective
high GI side effects
ketorolac (toradol) COX selectivity, potency, SE
non selective
up to 800 times more potent than ASA
can impair renal function, limit dose to 3-5 days
anthranilic acid NSAID example, selectivity, half life
meloxicam (Mobic)
COX2 selectivity at lower doses <15mg
half life 15-20 hours
Celecoxib (Celebrex) selectivity, elimination, considerations, uses
only highly selective COX2 inhibitor available in the US
hepatic elimination
does not interfere with platelet aggregation like other COX2’s
colon polyp tx, cancer, mental illness???
two brand names for acetaminophen include
paracetamol (Tylenol)
Propocetamol (IV tylenol)
paracetamol (tylenol) MOA, considerations, potential toxicity, toxic dose
MOA inhibition of prostaglandin synthesis, weak anti inflammatory effects. poor COX inhibition
no effect on platelet function or gastric mucosa
potential hepatic toxicity, toxic dose 200mg/kg
what is a use for IV tylenol (propocetamol)
reduced postop narcotic consumption